DAX23.970 -1,0%ESt505.338 -0,3%Top 10 Crypto16,23 +2,0%Dow44.838 -0,1%Nas21.179 +0,3%Bitcoin101.712 +0,1%Euro1,1594 ±0,0%Öl70,40 +2,9%Gold3.314 ±-0,0%
Beliebte Suche
DAX 40 Ölpreis Euro - Dollar Bitcoin - Euro Goldpreis
Meistgesucht
Rheinmetall 703000 NVIDIA 918422 Volkswagen (VW) vz. 766403 RENK RENK73 Mercedes-Benz Group (ex Daimler) 710000 Lufthansa 823212 Bayer BAY001 Deutsche Bank 514000 BASF BASF11 Tesla A1CX3T DroneShield A2DMAA Porsche PAG911 Novo Nordisk A3EU6F HENSOLDT HAG000 Deutsche Telekom 555750
Alle Aktien für 0 Euro (zzgl. Spreads) handeln mit finanzen.net zero. Hier informieren
Heute im Fokus
US-EU-Zolldeal im Blick: DAX schließt unter 24.000 Punkten -- US-Börsen letztlich uneins -- NVIDIA-Aktie: Huawei stellt Konkurrenzsystem vor -- Tilray, TUI, Clara Tech, D-Wave, PUMA, Intel im Fokus
Top News
Tilray-Aktie gibt nach: Tilray schockiert Anleger mit deutlich höherem Verlust Tilray-Aktie gibt nach: Tilray schockiert Anleger mit deutlich höherem Verlust
NVIDIA-Aktie trotzt Unsicherheit: Huawei stellt Konkurrenzsystem CloudMatrix 384 vor NVIDIA-Aktie trotzt Unsicherheit: Huawei stellt Konkurrenzsystem CloudMatrix 384 vor
Suche...
Login
ODER

Neu auf finanzen.net?

Kostenfrei registrieren und Vorteile nutzen

Ãœbersicht Wertpapierdepots Musterdepots Watchlists Meine News Newsletter Forum Trading Desk Apps Social Media Podcasts
Profil
Wer­bung
Deutscher Zertifikatepreis 2025: Jetzt abstimmen und attraktive Preise gewinnen!

Anixa Biosciences Aktie

Handeln
Aktien-Sparplan anlegen
2,82 EUR +0,12 EUR +4,44 %
BMN
3,26 USD +0,04 USD +1,24 %
BTT
Aktien, ETFs, Sparpläne & Kryptos zu Top-Konditionen beim Testsieger von finanztip.de handeln!
JETZT LOSLEGEN
Du hast schon ein ZERO-Konto? Direkt handeln bei ZERO!Bei einem anderen Broker handelnSmartphone

Marktkap.88,45 Mio. EUR

Div. Rendite0,00%
WKN wurde kopiert
NEU
Handle jetzt direkt über finanzen.net mit Deinem Broker
Direkt handeln

WKNA2N6ZF

ISIN wurde kopiert
NEU
Handle jetzt direkt über finanzen.net mit Deinem Broker
Direkt handeln

ISINUS03528H1095

Symbol wurde kopiert
NEU
Handle jetzt direkt über finanzen.net mit Deinem Broker
Direkt handeln

SymbolANIX

Anixa Biosciences Aktien News

DatumMeistgelesen
PR NewswireAnixa Biosciences Awarded New U.S. Patent Extending Breast Cancer Vaccine IP Protection into 2040s
PR NewswireAnixa Biosciences Announces Issuance of Additional U.S. Patent for Ovarian Cancer Vaccine Technology
PR NewswireAnixa Biosciences Initiates Dosing in Fourth Cohort in its Ovarian Cancer CAR-T Clinical Trial
Wer­bungAnixa Biosciences-Aktie für 0 Euro (zzgl. Spreads) handeln bei finanzen.net zero
PR NewswireAnixa Biosciences to Host an Investor Webcast on June 26, 2025
PR NewswireAnixa Biosciences Announces Poster Presentation on Ovarian Cancer CAR-T Clinical Trial at the ESMO Gynaecological Cancers Congress 2025
PR NewswireAnixa Biosciences Announces Completion of Enrollment in Phase 1 Trial of Breast Cancer Vaccine
PR NewswireAnixa Biosciences Announces Poster Presentation on Ovarian Cancer CAR-T Clinical Trial at the American Society of Clinical Oncology (ASCO) Annual Meeting
PR NewswireAnixa Biosciences to Present at the H.C. Wainwright 3rd Annual BioConnect Investor Conference on May 20th
PR NewswireAnixa Biosciences Receives Notice of Allowance from U.S. Patent and Trademark Office for CAR-T Technology, Further Strengthening its Robust Intellectual Property Portfolio
PR NewswireAnixa Biosciences Receives Notice of Allowance from U.S. Patent and Trademark Office for Patent Covering Breast Cancer Vaccine Technology
PR NewswireAnixa Biosciences to Present at the Jones Las Vegas Healthcare and Technology Innovation Conference on April 9th
PR NewswireAnixa Biosciences Enters Letter of Intent with VERDI Solutions to Develop Artificial Intelligence-Guided Personalized and Off-the-Shelf Cancer Vaccines
PR NewswireAnixa Biosciences Receives Notice of Allowance from USPTO for Ovarian Cancer Vaccine
PR NewswireAnixa Biosciences CEO to Present at the 2025 CAGLA NeauxCancer Conference on March 28th
PR NewswireAnixa Biosciences 2025 Annual Meeting of Stockholders to Include Investor Presentation Open to All Interested Parties
PR NewswireAnixa Biosciences Announces Chief Development Officer Dr. Pam Garzone to Speak at the Alliance for Cancer Gene Therapy Summit 2025 on March 19th
PR NewswireAnixa Biosciences and Moffitt Cancer Center Complete Dosing in Third Cohort in Ovarian Cancer CAR-T Clinical Trial
PR NewswireAnixa Biosciences' Breast Cancer Vaccine was Featured on Fox News' "America Reports"
PR NewswireAnixa Biosciences Featured in Breaking Cancer News Article on Novel CAR-T Therapy for Ovarian Cancer
PR NewswireAnixa Biosciences Announces Approval of Protocol Amendment for Ovarian Cancer CAR-T Clinical Trial
PR NewswireAnixa Biosciences Chairman and CEO Discusses Pioneering CAR-T Cell Therapy and Breast Cancer Vaccine in Alpha Wolf Trading Interview
PR NewswireAnixa Biosciences to Present at the 18th Annual European Life Sciences CEO Forum
PR NewswireAnixa Biosciences' Chairman & CEO Dr. Amit Kumar Featured on CW39's H-Town Live to Discuss the Future of Breast Cancer Prevention
PR NewswireAnixa Biosciences CEO Provides Letter to Shareholders
PR NewswireAnixa Biosciences to Present at the iAccess Alpha Virtual Best Ideas Winter Conference 2024 on December 10
PR NewswireAnixa Biosciences Board of Directors Approves Purchase of Bitcoin as Treasury Reserve Asset
PR NewswireAnixa Biosciences Initiates Dosing in Third Cohort in its Ovarian Cancer CAR-T Clinical Trial
PR NewswireAnixa Biosciences and Cleveland Clinic Present New Updated Positive Data from Phase 1 Study of Breast Cancer Vaccine at the 39th Society for Immunotherapy of Cancer (SITC) Annual Meeting
PR NewswireAnixa Biosciences Announces Timing of Public Release of Data from the Phase 1 Study of its Breast Cancer Vaccine at the 39th Society for Immunotherapy of Cancer (SITC) Annual Meeting
PR NewswireAnixa Biosciences to Present at the Sidoti Micro-Cap Virtual Conference on November 13 & 14, 2024
PR NewswireAnixa Biosciences and Cleveland Clinic to Present Additional Data from Phase 1 Study of Breast Cancer Vaccine at the 39th Society for Immunotherapy of Cancer (SITC) Annual Meeting
PR NewswireAnixa Biosciences Announces Second Dose Administered to Patient in Ovarian Cancer CAR-T Clinical Trial
PR NewswireAnixa Biosciences Appoints Suyasha Gupta as Senior Director of Clinical Development
PR NewswireAnixa Biosciences Announces Submission of Protocol Amendment for CAR-T Trial
PR NewswireAnixa Biosciences Unveils Phase 2 Study Plan for Breast Cancer Vaccine
PR NewswireAnixa Biosciences Announces Presentation on its Ovarian Cancer CAR-T Therapy at the Rivkin Center-AACR 15th Biennial Ovarian Cancer Research Symposium
PR NewswireAnixa Biosciences to Present at the H.C. Wainwright 26th Annual Global Investment Conference
PR NewswireAnixa Biosciences Announces Presentation on its Ovarian Cancer CAR-T Clinical Trial at the International Gynecologic Cancer Society 2024 Annual Meeting
PR NewswireAnixa Biosciences Announces FDA Approval of Individual Patient IND for its Ovarian Cancer CAR-T Therapy
PR NewswireAnixa Biosciences Announces Japanese Patent on Breast Cancer Vaccine Technology

Anixa Biosciences News

Anixa Biosciences News: auf dieser Seite finden Sie alle Anixa Biosciences News und Nachrichten zur Anixa Biosciences Aktie. Dies beinhaltet die Agentur-Feeds auf finanzen.net, aber auch Anixa Biosciences News auf einer Vielzahl externer Seiten. Externe Links sind am entsprechenden Link-Symbol zu erkennen. Um Anixa Biosciences News auf externen Seiten zu lesen, folgen Sie einfach dem entsprechenden Link.